BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Other Non-Current Liabilities (2021 - 2026)

BeyondSpring's (BYSI) quarterly Other Non-Current Liabilities came in at $4.4 million in Q2 2026, up 16.84% year-over-year from $3.8 million in Q2 2025, and up 4.27% quarter-over-quarter from $4.2 million in Q1 2026.

Analysis

BeyondSpring (BYSI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

BeyondSpring has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $4.4 million for Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities rose 16.84% year-over-year to $4.4 million; the TTM figure through Jun 2026 stood at $4.4 million (up 16.84% YoY), while the FY2025 annual figure was $4.0 million, up 8.0% from the prior year.
  • Other Non-Current Liabilities came in at $4.4 million for Q2 2026 at BeyondSpring, up from $4.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.4 million in Q2 2026 to a low of $692000.0 in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $3.6 million, with a median of $3.7 million recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities soared 416.36% in 2022 and decreased 0.51% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $3.7 million in 2022, then climbed by 1.2% to $3.7 million in 2023, then declined by 0.51% to $3.7 million in 2024, then climbed by 8.0% to $4.0 million in 2025, then increased by 11.03% to $4.4 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $4.4 million in Q2 2026, $4.2 million in Q1 2026, and $4.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 BeyondSpring 31.51 Mn 31.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.42 Mn
Mar 31, 2026 4.24 Mn
Dec 31, 2025 3.98 Mn
Sep 30, 2025 3.84 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 3.71 Mn
Dec 31, 2024 3.69 Mn
Jun 30, 2024 3.61 Mn
Dec 31, 2023 3.71 Mn
Jun 30, 2023 3.53 Mn
Dec 31, 2022 3.66 Mn
Jun 30, 2022 692,000.00
Dec 31, 2021 709,000.00
Sep 30, 2021 1.26 Mn
Jun 30, 2021 341,000.00
Mar 31, 2021 278,000.00